Skip to main navigation
Skip to main content
  • Investors & Media
    • Overview
    • Newsroom
    • Events
    • Financial Information
    • Stock Information & Analyst Coverage
    • FAQs
  • Careers
  • Partnerships & Business Development
  • Contact Us
  • Investors & Media
    • Overview
    • Newsroom
    • Events
    • Financial Information
    • Stock Information & Analyst Coverage
    • FAQs
  • Our Company
    • The Esperion Story
    • Leadership Team
    • Board of Directors
    • Ethics and Compliance
    • Corporate Governance & Committee Composition
  • Patients
    • Cholesterol Education
    • Unmet Need
    • Patient Advocacy and Resources
  • Products
  • Science
    • Pipeline
    • Clinical Trials
    • Expanded Access
    • Grants
/investors-media

Investors and Media

Latest News

May 17, 2022
Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference
May 03, 2022
Esperion Reports First Quarter 2022 Financial Results and Provides Company Update

View All News Dark Blue

  • View All News
Show all

Latest Quarterly Results

  • Esperion Reports First Quarter 2022 Financial Results and Provides Company Update
  • Form 10-Q

View All Earnings

  • View All Earnings

Corporate Presentation

Download PDF

Events

Upcoming Events

May 26, 2022 at 8:00 AM EDT
Esperion Therapeutics, Inc. 2022 Annual Meeting of Stockholders
Jun 8, 2022 at 9:00 AM EDT
Jeffries Healthcare Conference

Past Events

May 24, 2022 at 7:00 AM EDT
H.C. Wainwright Global Investment Conference
May 10, 2022 at 6:20 PM EDT
Bank of America Securities 2022 Healthcare Conference

View All Events

  • View All Events

Page Tools

Our Company

  • Our Company
    • The Esperion Story
    • Leadership Team
    • Board of Directors
    • Ethics and Compliance
    • Corporate Governance & Committee Composition

Patients

  • Patients
    • Cholesterol Education
    • Unmet Need
    • Patient Advocacy and Resources

Products

  • Products

Science

  • Science
    • Pipeline
    • Clinical Trials
    • Expanded Access
    • Grants

Careers

  • Careers

Partnerships & Business Development

  • Partnerships & Business Development

Investors & Media

  • Investors & Media
    • Overview
    • Newsroom
    • Events
    • Financial Information
    • Stock Information & Analyst Coverage
    • FAQs

Contact Us

  • Contact Us

All trademarks and trade names are the property of their respective owners.

© 2022 Esperion Therapeutics, Inc. All rights reserved. 05/20 US-CRP-2000082

Utility

  • Privacy Policy
  • Terms of Use
  • Accessibility Statement
  • Social Media Community Guidelines

Search

Share this page